Novartis AG
NVSNASDAQStock · Data from SEC EDGAR 13F · Held by 8 of 87 tracked investors
Novartis AG at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation61
- Growth61
- Profitability90
- Quality92
- Debt66
- Stability100
- ✓Out of 100 USD of revenue, 23 USD is left as net profit.
- ✓It earns 30 USD a year on every 100 USD of invested capital (ROE).
- ✓Revenue grew 9.3% a year over 3 years.
- Nothing notable from the statements.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
Reasonably pricedFor 1 USD of annual earnings you pay 23.7 USD. Based on next year's estimates 16.0 USD.
- P/E
- 23.7×
- P/S
- 5.3×
- EV/EBITDA
- 14.5×
Is the company growing?
GrowingRevenue over 3 years grew 9.3% a year. Last year 0.8%.
Does it make money?
ExcellentEarnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 21 Jul 2026 | 2.41 | 2.20 | +9.6% |
| Mar 2026 | 28 Apr 2026 | 1.99 | 2.11 | -5.7% |
| Dec 2025 | 4 Feb 2026 | 2.03 | 1.99 | +2% |
| Sep 2025 | 28 Oct 2025 | 2.25 | 2.26 | -0.4% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart NVS
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
8KF Ken Fisher Fisher Investments | 0.72% |
LR Larry Robbins Glenview Capital | 0.25% |
JS Jim Simons Renaissance Technologies | 0.17% |
GI Generali Investments CEE Generali Investments CEE | 0.09% |
IE Israel Englander Millennium Management | 0.04% |
LA Lee Ainslie Maverick Capital | 0.04% |
SC Steven Cohen Point72 Asset Management | 0.02% |
CA Cliff Asness AQR Capital Management | 0.02% |
Frequently asked questions
How much is Novartis AG (NVS) stock?
Novartis AG shares trade at $156.86, +1.98% over the last trading day. The price is delayed.
What is the market cap of Novartis AG?
The market cap of Novartis AG is about $298B and its price-to-earnings ratio (P/E) is 23.7.
Which big investors hold Novartis AG?
According to the latest 13F filings, 8 of 87 tracked investors hold Novartis AG, for example Ken Fisher, Larry Robbins, Jim Simons.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.